Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review
Renee E. Vickman, Omar E. Franco, Daniel Moline, et al.
Asian journal of urology (2019) Vol. 7, Iss. 3, pp. 191-202
Open Access | Times Cited: 131

Showing 1-25 of 131 citing articles:

TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease
Renee E. Vickman, LaTayia Aaron-Brooks, Renyuan Zhang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 46
Symptomatic Benign Prostatic Hyperplasia with Suppressed Epigenetic Regulator HOXB13 Shows a Lower Incidence of Prostate Cancer Development
Nimrod S. Barashi, Tiandao Li, Duminduni H. Angappulige, et al.
Cancers (2024) Vol. 16, Iss. 1, pp. 213-213
Open Access | Times Cited: 8
Molecular pathways in reproductive cancers: a focus on prostate and ovarian cancer
Ayodeji Folorunsho Ajayi, Mega Obukohwo Oyovwi, Oyedayo Phillips Akano, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
A sustainable approach in pumpkin seed oil processing line: Recent advances in pumpkin seed oil and oil processing by-products
Guoqiang Zhang, Jing Guo, Jinying Guo
Food Chemistry X (2025) Vol. 26, pp. 102259-102259
Open Access | Times Cited: 1
Oxidative Stress in Benign Prostatic Hyperplasia: Mechanisms, Clinical Relevance and Therapeutic Perspectives
Aris Kaltsas, Timoleon Giannakas, M. Stavropoulos, et al.
Diseases (2025) Vol. 13, Iss. 2, pp. 53-53
Open Access | Times Cited: 1
Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
Abdolreza Haghpanah, Fatemeh Masjedi, Mehdi Salehipour, et al.
Prostate Cancer and Prostatic Diseases (2021) Vol. 25, Iss. 1, pp. 27-38
Open Access | Times Cited: 41
Ellagic acid improves benign prostate hyperplasia by regulating androgen signaling and STAT3
Woo Yong Park, Gahee Song, Ja Yeon Park, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 37
Anti-Androgen Receptor Therapies in Prostate Cancer: A Brief Update and Perspective
Jian Huang, Biyun Lin, Benyi Li
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 32
Overview of BPH: Symptom Relief with Dietary Polyphenols, Vitamins and Phytochemicals by Nutraceutical Supplements with Implications to the Prostate Microbiome
Kendal Stewart, Edwin D. Lephart
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5486-5486
Open Access | Times Cited: 22
Targeting benign prostate hyperplasia treatments: AR/TGF-β/NOX4 inhibition by apocynin suppresses inflammation and proliferation
Bo‐Ram Jin, Hyo-Jung Kim, Jung‐Hyun Na, et al.
Journal of Advanced Research (2023) Vol. 57, pp. 135-147
Open Access | Times Cited: 13
Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer
Weronika Ratajczak, Michał Lubkowski, Anna Lubkowska
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 897-897
Open Access | Times Cited: 20
Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients
Claire E. Stevens, Alexandria Hightower, Sarah G. Buxbaum, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Recent advances in dietary androgen receptor inhibitors
Li Ren, Tiehua Zhang, Jie Zhang
Medicinal Research Reviews (2024) Vol. 44, Iss. 4, pp. 1446-1500
Closed Access | Times Cited: 4
Effects of Taraxaci Herba (Dandelion) on Testosterone Propionate-Induced Benign Prostatic Hyperplasia in Rats
Seong Min Lee, Sang Mok Lee, Jungbin Song
Nutrients (2024) Vol. 16, Iss. 8, pp. 1189-1189
Open Access | Times Cited: 4
Ondansetron Alleviates Testosterone-Induced BPH in Rats Through Cross Regulation of the 5-HT/AR/P-STAT3 and the Non-Canonical NF-κB Pathways
Reem A. Mohamed, Maha Shouman
European Journal of Pharmacology (2025) Vol. 991, pp. 177331-177331
Closed Access
Reduction of Prostate Cancer Risk: Role of Frequent Ejaculation-Associated Mechanisms
Mohamed Hassan, Thomas W. Flanagan, Abdulaziz M. Eshaq, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 843-843
Open Access
Comparison of the efficacy and safety of holmium laser enucleation of the prostate and prostate artery embolization: Short-term follow-up results
E. Lim, Hui Mo Gu, Seong Hyeon Yu, et al.
Prostate International (2025)
Open Access
Conditioned Media Derived from WJ-MSCs Enhanced the Inhibition Effect of EGCG on LNCaP Cells by Targeting Androgen Receptor and Apoptosis Pathway
Reihane Mohammadi, Zahra Fazeli, Azam Daraei, et al.
International Journal of Cancer Management (2025) Vol. 18, Iss. 1
Open Access
Predicting the pathological subdiagnosis of benign prostatic hyperplasia with MRI radiomics: A noninvasive approach
Jun Wang, Weiqing Tang, Zhu Jun, et al.
View (2025)
Open Access
A comment on oral phenylephrine use in sinonasal pathologies
Syed Ahmed Shahzaeem Hussain, Muhammad Talha, Muhammad Faizan Tariq
European Archives of Oto-Rhino-Laryngology (2025)
Closed Access
Therapeutic targets for benign prostatic hyperplasia: proteome-wide Mendelian randomization and colocalization analysis
Haolin Teng, Jinyu Yu, Honglan Zhou, et al.
Journal of Taibah University for Science (2025) Vol. 19, Iss. 1
Open Access
Exploring TGF-β signaling in benign prostatic hyperplasia: from cellular senescence to fibrosis and therapeutic implications
Abida Khan, Hayat Alzahrani, Shatha Ghazi Felemban, et al.
Biogerontology (2025) Vol. 26, Iss. 2
Closed Access
Exploring the use of phytotherapy in benign prostatic hyperplasia [BPH]: a systematic review
Herbert Mbyemeire, Ilemobayo Victor Fasogbon, Angela Mumbua Musyoka, et al.
F1000Research (2025) Vol. 14, pp. 412-412
Open Access
Synergetic Impact of Combined rutin and Exosme on Apoptosis in Prostate Cancer Cells
Maysa Alhawamdeh
Research Journal of Pharmacy and Technology (2025), pp. 1324-1329
Closed Access
Protective effect of the hydroethanolic extract of camelthorn (Alhagi maurorum) on benign prostatic hyperplasia induced by testosterone in rats
Fatemeh Hoseinpour, Mohammad Hashemnia, Hadi Cheraghi, et al.
BMC Complementary Medicine and Therapies (2025) Vol. 25, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top